MedTrace Logo

Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews

NCT03054389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2021-04-23

No results posted yet for this study

Summary

The purpose of this study is to seek to understand the patient's perspective around deciding to participate in a clinical trial for a Hemophilia therapy

Conditions

  • Hemophilia B

Interventions

OTHER

Qualitative Interview - Participants/ Patients

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Participants/ Patients

OTHER

Qualitative Interview - Investigators and Study Coordinators

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators

Sponsors & Collaborators

  • Baxalta now part of Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-31
Primary Completion
2017-06-06
Completion
2017-06-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03054389 on ClinicalTrials.gov